Fangerau T, Schimrigk S, Haupts M, Kaeder M, Ahle G, Brune N, Klinkenberg K, Kotterba S, Möhring M, Sindern E:
Diagnosis of Multiple Sclerosis: Comparison of the Poser criteria and the new McDonald criteria.
Acta Neurol Scand 109, 2004, 385-389.

Sindern E:
Role of chemokines and their receptors in the pathogenesis of multiple sclerosis.
Front Biosci 9, 2004, 457-463.

Züchner S, Vorgerd M, Sindern E, Schröder JM:
The novel neurofilament light (NEFL) mutation Glu397Lys is associated with clinically and morphologically heterogenous type of Charcot-Marie-Tooth neuropathy.
Neuromuscular Disorders, 2004.

Kotterba S, Eren E, Fangerau T, Malin JP, Sindern E:
Differenzierung von Müdigkeit und Fatigue bei Multipler Sklerose - Vergleich unterschiedlicher Messinstrumente.
Fortschr Neurol Psychiatr 71, 2003, 590

Kotterba S, Orth M, Eren E, Fangerau T, Sindern E:
Assessment of driving performance in relapsing remitting multiple sclerosis by driving simulator.
Eur Neurol 50, 2003, 160-164.-594.

Sindern E, Ziemsen F, Ziemsen T, Podskarbi T, Shin Y, Brasch F, Müller KM, Schröder JM, Malin JP, Vorgerd M:
Adult polyglucosan body disease: A postmortem correlation study.
Neurology 61, 2003, 263-265.

Goedde R, Sawcer S, Boehringer S, Miterski B, Sindern E, Haupts M, Schimrigk S, Epplen JT:
A genome screen for linkage disequilibrium in HLA-DRB1*15-positive Germans with multiple sclerosis based on 4666 microsatellite markers.
Hum Genet 111, 2002, 270-277.

Miterski B, Boehringer S, Klein W, Sindern E, Haupts M, Schimrigk S, Epplen JT:
Inhibitors in the NFkB cascade comprise prime candidate genes predisposing to multiple sclerosis, especially in selected combinations.
Genes Immun 3, 2002, 211-219.

Patzold T, Schwengelbeck M, Ossege LM, Malin JP, Sindern E:
Changes of the MS Functional Composite and EDSS during and after treatment of relapses with methylprednisolone in patients with Multiple Sclerosis.
Acta Neurol Scand 105, 2002, 164-168.

Miterski B, Sindern E, Haupts M, Schimrigk S, Epplen JT.
PTPRC (CD45) is not associated with multiple sclerosis in a large cohort of German patients.
BMC Med Genet 3, 2002, 3-8.

Sindern E, Patzold T, Ossege LM, Gisevius A, Malin JP:
Expression of chemokine receptor CXCR3 on cerebrospinal fluid T-cells is related to active MRI lesion appearance in patients with relapsing-remitting multiple sclerosis.
J Neuroimmunol 131, 2002, 186

Sindern E, Schröder JM, Krisman M, Malin JP:
Inflammatory polyradiculoneuropathy with spinal cord involvement and lethal outcome after hepatitis B vaccination.
J Neurol Sci 186, 2001,

Ossege LM, Sindern E, Patzold T, Malin JP:
Immunmodulatory effects of Interferon-beta-1b in patients with multiple sclerosis.
Int Immunopharmacol 1, 2001, 1085-1

Sindern E, Niederkinkhaus Y, Henschel M, Ossege LM, Patzold T, Malin JP:
Differential release of ß-chemokines in serum and CSF of patients with relapsing-remitting multiple sclerosis.
Acta Neurol Scand 104, 2001, 88-91.100.81-85. -19

Ziemsen F, Sindern E, Schröder JM, Shin YS, Zange J, Kilimann MW, Malin JP, Vorgerd M:
Novel missense mutations in the glycogen branching enzyme gene in adult polyglucosan body disease (APBD).
Ann Neurol 47, 2000, 536-540.0.

Ossege LM, Sindern E, Voss B, Malin JP:
Expression of TNFa and TGFß1 in Guillain Barré syndrome: correlation of a low TNFa-/TGFß1-mRNA ratio with good recovery and signs for immunoregulation within the cerebrospinal fluid compartment.
Eur J Neurol 7, 2000, 17-25.

Miterski B, Jaeckel S, Pöhlau D, Hardt C, Haupts M, Sindern E, Epplen JT:
The interferon gene cluster: a candidate region for MS predisposition?
Genes and Immun 1, 1999, 37-44.

Schulze W, Laczkovics A, Richter J, Sindern E:
Thymektomie bei Myasthenia gravis - eine Standortanalyse.
Chirurg 69, 1998, 1345-1351.

Ossege LM, Sindern E, Patzold T, Malin JP:
Immunomodulatory effects of interferon-ß-1b in vivo: induction of the expression of transforming growth factor-ß1 and ist receptor type II.
J. Neuroimmunol. 91, 1998, 73-81.

Oreja-Guevara C, Sindern E, Raulf-Heimsoth M, Malin JP:
Analysis of lymphocyte subpopulations in cerebrospinal fluid and peripheral blood in patients with multiple sclerosis and inflammatory diseases of the nervous system.
Act Neurol. Scand. 98, 1998, 310-313.

Patzold T, Sindern E, Ossege LM, Malin JP:
The soluble 60kDa TNF receptor: No difference between patients with relapsing-remitting MS and controls; increasing levels are associated with the recovery from Guillain-Barré syndrome.
J Neurol 245, 1998, 803-808.

Ossege LM, Sindern E, Voss B, Malin JP:
Corticosteroids induce expression of transforming-groth-factor-beta1 mRNA in peripheral blood mononuclear cells of patients with multiple sclerosis.
J Neuroimmunol 84, 1998, 1-6.

Sindern E, Oreja-Guevara C, Raulf-Heimsoth M, Baur X, Malin JP:
A longitudinal study of circulating lymphocyte subsets in the peripheral blood during the acute stage of Guillain- Barré syndrome.
J Neurol Sci 151, 1997, 29-34.

Rollnik JD, Sindern E, Schweppe C, Malin JP:
Biologically active TGF-ß1 is increased in cerebrospinal fluid while it is reduced in serum in multiple sclerosis patients.
Acta Neurol Scand 96, 1997, 101-105.

Epplen C, Jäckel S, Santos EJM, D`Souza M, Poehlau D, Dotzauer B, Sindern E, Haupts M, Rüde P, Weber F, Poser S, Gehlen W, Malin JP, Przuntek H, Epplen JT:
Genetic predisposition to multiple sclerosis as revealed by immunoprinting.
Ann Neurol 41, 1997, 341-352.

Ossege LM, Sindern E, Voss B, Malin JP:
Expression of tumor necrosis factor-alpha and transforming growth factor-ß1 mRNA in cerebrospinal fluid cells in meningitis.
J Neurol Sci 144, 1996, 1-13.

Rollnik JD, Sindern E, Mosler F, im Spring B, Malin JP:
Isolated peripheral hypoglossal palsy caused by a kinking of the left vertebral artery - Hypoglossal vertebral entrapment syndrome.
Eur Neurol 36, 1996, 324-325.

Sindern E, Schweppe K, Ossege LM, Malin JP:
Potential role of transforming growth factor-ß1 in terminating the immune response in patients with Guillain-Barré syndrome.
J Neurol 243, 1996, 264-268.

Sindern E, Ossege LM, Oreja C, Malin JP:
Klinische Bedeutung hoher anti-GM1-Antikörper bei Patienten mit akutem Guillain-Barré-Syndrom.
Akt Neurol 22, 1995, 136-139.

Sindern E, Malin JP:
Phenotypic analysis of cerebrospinal fluid cells over the course of Lyme meningoradikulitis.
Acta Cytol 39, 1995, 73-76.

Ossege LM, Voss B, Wiethege T, Sindern E, Malin JP:
Detection of transforming growth factor beta 1 mRNA in cerebrospinal fluid cells of patients with meningitis by non-radioactive in situ hybridization.
J Neurol 242, 1994, 14-19.

Sindern E, Burghardt F, Voigtmann R, Malin JP:
Cerebrospinal fluid cytology in granulocytic sarcoma with meningeal extension but without bone marrow involvement.
J Neurol 241, 1994, 320-322.

Sindern E, Gläser E, Bötel U, Malin JP:
Spondylodiscitis mit spinaler und radikulärer Beteiligung - Grenzen der konservativen Behandlung.
Nervenarzt 64, 1993, 801-805.

Sindern E, Sailer M, Stark E, Haas J:
Liquorcytologische Befunde bei HIV-infizierten Patienten mit neurologischen Symptomen.
Akt Neurol 20, 1993, 11-15.

Sindern E, Haas J, Stark E, Wurster U:
Early onset MS under the age of 16: clinical and paraclinical features.
Acta Neurol Scand 86, 1992, 280-284.

Sindern E, Stark E, Haas J, Steck AJ:
Serum antibodies to GM1- and GM3-gangliosides in systemic lupus erythematodes with chronic inflammatory demyelinating polyradikuloneuropathy.
Acta Neurol Scand 83, 1991, 399-402.